Swiss Life Asset Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
20,621
-1,591
-7% -$77.5K ﹤0.01% 673
2026
Q1
$953K Buy
22,212
+3,797
+21% +$163K ﹤0.01% 670
2025
Q4
$807K Buy
18,415
+6,381
+53% +$264K ﹤0.01% 678
2025
Q3
$497K Buy
12,034
+5,513
+85% +$222K ﹤0.01% 722
2025
Q2
$287K Buy
+6,521
New +$261K ﹤0.01% 733

Other funds holding EXEL

Swiss Life Asset Management's EXEL Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Exelixis (EXEL) stake by 7.2% in Q2 2026, selling an estimated $77.5K and leaving 20,621 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Swiss Life Asset Management first reported a position in EXEL in Q2 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Swiss Life Asset Management held 20,621 shares of Exelixis worth $1.12M as of Q2 2026.
  • Swiss Life Asset Management sold 1,591 Exelixis shares in Q2 2026, an estimated $77.5K.
  • Exelixis made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #673 holding.
  • Swiss Life Asset Management first reported a position in Exelixis in Q2 2025 and has held it in 5 quarters since.
  • 598 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.